Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0QM0N
|
||||
Former ID |
DIB010771
|
||||
Drug Name |
BILD-733
|
||||
Indication | Herpes simplex virus infection [ICD9: 54; ICD10:B00] | Terminated | [1] | ||
Company |
Boehringer Ingelheim Corp
|
||||
Structure |
![]() |
Download2D MOL |
|||
Canonical SMILES |
C1([C@@H](C(=O)N[C@@H](CC(C)(C)C)CO)NC(=O)[C@H](CC(=O)N<br />2CCCC2)NC(=O)[C@@H](NC(=O)[C@@H](N(C(=O)CCc2ccccc2)C)C(<br />C)C)C(C)(C)C)(C(=O)O)CCCC1
|
||||
CAS Number |
CAS 144096-13-9
|
||||
Target and Pathway | |||||
Target(s) | Ribonucleoside-diphosphate reductase | Target Info | Inhibitor | [2] | |
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004139) | ||||
REF 2 | Resistance of herpes simplex virus type 1 to peptidomimetic ribonucleotide reductase inhibitors: selection and characterization of mutant isolates. J Virol. 1996 Feb;70(2):787-93. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.